BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16175026)

  • 1. Vasoactive drugs in the intensive care unit.
    Holmes CL
    Curr Opin Crit Care; 2005 Oct; 11(5):413-7. PubMed ID: 16175026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
    Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
    Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L; Wang P; Li C; Xie J
    Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
    Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
    Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL; Walley KR
    Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
    Morelli A; Ertmer C; Lange M; Dünser M; Rehberg S; Van Aken H; Pietropaoli P; Westphal M
    Br J Anaesth; 2008 Apr; 100(4):494-503. PubMed ID: 18308741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.
    Albanèse J; Leone M; Delmas A; Martin C
    Crit Care Med; 2005 Sep; 33(9):1897-902. PubMed ID: 16148457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?].
    Fellahi JL; Bénard P; Daccache G; Mourgeon E; Gérard JL
    Ann Fr Anesth Reanim; 2003 Jul; 22(7):631-4. PubMed ID: 12946495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic support in septic shock: a critical review.
    Póvoa P; Carneiro AH
    Hosp Pract (1995); 2010 Feb; 38(1):62-73. PubMed ID: 20469626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.
    Rehberg S; Ertmer C; Köhler G; Spiegel HU; Morelli A; Lange M; Moll K; Schlack K; Van Aken H; Su F; Vincent JL; Westphal M
    Intensive Care Med; 2009 Jul; 35(7):1286-96. PubMed ID: 19360396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of terlipressin on patients with sepsis via improving tissue blood flow.
    Xiao X; Zhang J; Wang Y; Zhou J; Zhu Y; Jiang D; Liu L; Li T
    J Surg Res; 2016 Jan; 200(1):274-82. PubMed ID: 26253455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin for norepinephrine-resistant septic shock.
    O'Brien A; Clapp L; Singer M
    Lancet; 2002 Apr; 359(9313):1209-10. PubMed ID: 11955542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
    Morelli A; Ertmer C; Pietropaoli P; Westphal M
    Expert Opin Pharmacother; 2009 Oct; 10(15):2569-75. PubMed ID: 19735216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terlipressin infusion in catecholamine-resistant shock.
    Jolley DH; De Keulenaer BL; Potter A; Stephens DP
    Anaesth Intensive Care; 2003 Oct; 31(5):560-4. PubMed ID: 14601280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin in catecholamine-resistant septic shock patients.
    Leone M; Albanèse J; Delmas A; Chaabane W; Garnier F; Martin C
    Shock; 2004 Oct; 22(4):314-9. PubMed ID: 15377885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.
    Morelli A; Rocco M; Conti G; Orecchioni A; De Gaetano A; Cortese G; Coluzzi F; Vernaglione E; Pelaia P; Pietropaoli P
    Intensive Care Med; 2004 Apr; 30(4):597-604. PubMed ID: 14673520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.